Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pasithea Therapeutics Corp (KTTA)
NASDAQ:KTTA
RESEARCH TOOLSreports
Holding KTTA?
Track your performance easily
KTTA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.92 - $17.42
Previous Close$3.18
Volume17.30K
Average Volume (3M)948.00K
Market Cap
$4.03M
Enterprise Value-$5.37M
Total Cash (Recent Filing)$9.40M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.85
Next Earnings
Mar 30, 2022EPS Estimate
-$1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-15.13
Shares Outstanding1,266,427
10 Day Avg. Volume94,602
30 Day Avg. Volume948,003
Standard Deviation0.21
R-Squared0.04
Alpha-0.06
Financial Highlights & Ratios
Price to Book (P/B)0.23
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.75
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KTTA FAQ
What was Pasithea Therapeutics Corp’s price range in the past 12 months?
Pasithea Therapeutics Corp lowest stock price was $2.92 and its highest was $17.41 in the past 12 months.
What is Pasithea Therapeutics Corp’s market cap?
Currently, no data Available
When is Pasithea Therapeutics Corp’s upcoming earnings report date?
Pasithea Therapeutics Corp’s upcoming earnings report date is Mar 30, 2022 which is 969 days ago.
How were Pasithea Therapeutics Corp’s earnings last quarter?
Currently, no data Available
Is Pasithea Therapeutics Corp overvalued?
According to Wall Street analysts Pasithea Therapeutics Corp’s price is currently Overvalued.
Does Pasithea Therapeutics Corp pay dividends?
Pasithea Therapeutics Corp does not currently pay dividends.
What is Pasithea Therapeutics Corp’s EPS estimate?
Pasithea Therapeutics Corp’s EPS estimate is -$1.
How many shares outstanding does Pasithea Therapeutics Corp have?
Pasithea Therapeutics Corp has 1,266,427 shares outstanding.
What happened to Pasithea Therapeutics Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Pasithea Therapeutics Corp?
Currently, no hedge funds are holding shares in KTTA
---
Pasithea Therapeutics Corp Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-50.62%
12-Months-Change
Fundamentals
Return on Equity
-68.24%
Trailing 12-Months
Asset Growth
-39.21%
Trailing 12-Months
Company Description
Pasithea Therapeutics Corp
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.
---
Technical Analysis
---